Limes Schlosskliniken Stock
Limes Schlosskliniken Stock price
Key metrics
| Market capitalization | €92.06m |
| Enterprise Value | €92.90m |
| P/E (TTM) P/E ratio | 21.83 |
| EV/Sales (TTM) EV/Sales | 2.16 |
| P/S ratio (TTM) P/S ratio | 2.14 |
| P/B ratio (TTM) P/B ratio | 5.49 |
| Revenue growth (TTM) Revenue growth | 39.84% |
| Revenue (TTM) Revenue | €43.00m |
| EBIT (operating result TTM) EBIT | €5.44m |
Is Limes Schlosskliniken a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.
Limes Schlosskliniken Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Limes Schlosskliniken:
Analyst Opinions
1 Analyst has issued a forecast Limes Schlosskliniken:
Financial data from Limes Schlosskliniken
| Jun '24 |
+/-
%
|
||
| Revenue | 43 43 |
40%
40%
|
|
| Gross Profit | 41 41 |
39%
39%
|
|
| EBITDA | 8.31 8.31 |
12%
12%
|
EBIT (Operating Income) EBIT | 5.44 5.44 |
13%
13%
|
| Net Profit | 4.28 4.28 |
32%
32%
|
|
In millions EUR.
Don't miss a Thing! We will send you all news about Limes Schlosskliniken directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Limes Schlosskliniken Stock News
Company Profile
Limes Schlosskliniken AG engages in the operation of clinics and healthcare facilities. The firm provides medical and diagnostic services in the fields of psychiatry, psychotherapy, and psychosomatic medicine. It also offers psychological assessment, psychiatric treatment and therapy, awareness and breathing exercises, meditation, yoga, personal training, acupuncture, ergotherapy, as well as nutrition counselling. The company was founded by Gert Michael Frank on December 1, 2005 and is headquartered in Cologne, Germany.
| Head office | Germany |
| CEO | Gert Frank |
| Employees | 210 |
| Founded | 2005 |
| Website | www.limes-schlosskliniken.de |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
